Biosynthesis of UDP-GlcA, a key metabolite for capsular polysaccharide synthesis in the pathogenic fungus Cryptococcus neoformans

被引:44
作者
Maor, BP
Griffith, CL
Ory, JJ
Doering, TL
机构
[1] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA
[2] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA
关键词
capsule; Cryptococcus neoformans; pathogenic fungi; UDP-GlcA; UDP-glucose dehydrogenase;
D O I
10.1042/BJ20031075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
UDP-glucose dehydrogenase catalyses the conversion of UDPglucose into UDP-GlcA, a critical precursor for glycan synthesis across evolution. We have cloned the gene encoding this important enzyme from the opportunistic pathogen Cryptococcus neoformans. In this fungus, UDP-GlcA is required for the synthesis of capsule polysaccharides, which in turn are essential for virulence. The gene was expressed in Escherichia coli and the 51.3-kDa recombinant protein from wild-type and five mutants was purified for analysis. The cryptococcal enzyme is strongly inhibited by UDP-xylose and NADH, has highest activity at pH 7.5 and demonstrates K-m (app) values of 0.1 and 1.5 mM for NAD(+) and UDP-glucose respectively. Its activity was significantly decreased by mutations in the putative sites of NAD(+) and UDP-glucose binding. Unlike previously reported eukaryotic UDP-glucose dehydrogenases, which are hexamers, the cryptococcal enzyme is a dimer.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 35 条
[1]   MOLECULAR CHARACTERIZATION OF CAP3A, A GENE FROM THE OPERON REQUIRED FOR THE SYNTHESIS OF THE CAPSULE OF STREPTOCOCCUS-PNEUMONIAE TYPE-3 - SEQUENCING OF MUTATIONS RESPONSIBLE FOR THE UNENCAPSULATED PHENOTYPE AND LOCALIZATION OF THE CAPSULAR CLUSTER ON THE PNEUMOCOCCAL [J].
ARRECUBIETA, C ;
LOPEZ, R ;
GARCIA, E .
JOURNAL OF BACTERIOLOGY, 1994, 176 (20) :6375-6383
[2]   Functional cloning and characterization of a UDP-glucuronic acid decarboxylase:: The pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis [J].
Bar-Peled, M ;
Griffith, CL ;
Doering, TL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (21) :12003-12008
[3]  
BARPELED M, 1991, J BIOL CHEM, V266, P20953
[4]   DECARBOXYLATION OF URIDINE DIPHOSPHATE-D-GLUCURONIC ACID BY AN ENZYME PREPARATION FROM HEN OVIDUCT [J].
BDOLAH, A ;
FEINGOLD, DS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1965, 21 (06) :543-&
[5]  
Binari RC, 1997, DEVELOPMENT, V124, P2623
[6]   A yeast under cover:: the capsule of Cryptococcus neoformans [J].
Bose, I ;
Reese, AJ ;
Ory, JJ ;
Janbon, G ;
Doering, TL .
EUKARYOTIC CELL, 2003, 2 (04) :655-663
[7]   What makes Cryptococcus neoformans a pathogen? [J].
Buchanan, KL ;
Murphy, JW .
EMERGING INFECTIOUS DISEASES, 1998, 4 (01) :71-83
[8]   Properties and kinetic analysis of UDP-glucose dehydrogenase from group a streptococci - Irreversible inhibition by UDP-chloroacetol [J].
Campbell, RE ;
Sala, RF ;
vandeRijn, IV ;
Tanner, ME .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3416-3422
[9]   The first structure of UDP-glucose dehydrogenase reveals the catalytic residues necessary for the two-fold oxidation [J].
Campbell, RE ;
Mosimann, SC ;
van de Rijn, I ;
Tanner, ME ;
Strynadka, NCJ .
BIOCHEMISTRY, 2000, 39 (23) :7012-7023
[10]  
Casadevall A, 1998, CRYPTOCOCCUS NEOFORM, DOI DOI 10.1128/9781555818241